New study: Delaying 2nd Pfizer COVID vaccine dose can result in stronger antibody response

Researchers at the University of Birmingham found antibodies were three and a half times higher when the second dose of the Pfizer COVID-19 vaccine was given 12 weeks after the first, as opposed to the recommended three week interval. UCSF infectious disease specialist Dr. Peter Chin Hong offers his analysis.